The Tuberculosis Drug Accelerator at year 10: what have we learned?
Nature Medicine; July 5, 2021
Shailab Shrestha, MERGE-ID Ph.D. Candidate and Recipient of the Tufts GSBS Fellowship For International Students
PhD Candidate in Molecular Microbiology, MERGE-ID (Medically-oriented Research in Graduate Education – Infectious Disease) track at Tufts University’s Graduate School of Biomedical Sciences; Inaugural Recipient, Tufts University Graduate School of Biomedical Sciences Fellowship Supporting International Student Education, 2018
From Detection to Predicting Infectious Disease and Antibiotic Resistance Outcomes: Employing Experimental Evolution, Omics-Stress Mapping and Computational Biology to Determine and Predict What Matters in Antibiotic Resistance
Tim van Opijnen, PhD, an Associate Professor of Biology at Boston College and an Affiliate member of the Levy CIMAR, presented for our May 2021 Levy CIMAR Science Lunch on his group's work on antimicrobial resistance. His talk was titled,
Courtney Chan, Infection Prevention Coordinator, Medical Scribe, and Researcher
Infection Prevention Coordinator and Infectious Diseases Clinic Medical Scribe at Tufts Medical Center; Research contributor and co-author with the Levy CIMAR’s Drs. Maya Nadimpalli and Shira Doron: “Antibiotic Resistance: A Call to Action to Prevent the Next Epidemic of Inequality,”
Eve Abraha, Undergraduate Researcher and Co-Teacher
Undergraduate Researcher at Tufts Medical Center working with the Levy CIMAR’s Dr. Shira Doron; Co-teacher in the PARE (Prevalence of Antibiotic Resistance in the Environment) program’s short course, PARE-Seq, under the guidance of the Levy CIMAR’s Drs. Carol Bascom-Slack and